Form 8-K - Current report:
SEC Accession No. 0001193125-24-235251
Filing Date
2024-10-09
Accepted
2024-10-09 16:37:59
Documents
13
Period of Report
2024-10-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d851320d8k.htm   iXBRL 8-K 23758
  Complete submission text file 0001193125-24-235251.txt   141967

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20241007.xsd EX-101.SCH 2843
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20241007_lab.xml EX-101.LAB 17237
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20241007_pre.xml EX-101.PRE 10808
16 EXTRACTED XBRL INSTANCE DOCUMENT d851320d8k_htm.xml XML 3533
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

EIN.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 241363132
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)